MALDI imaging of post‐mortem human spinal cord in amyotrophic lateral sclerosis
暂无分享,去创建一个
Jonas Bergquist | Jörg Hanrieder | J. Bergquist | M. Andersson | Malin Andersson | Titti Ekegren | Jörg Hanrieder | T. Ekegren
[1] R. Cooks,et al. Desorption electrospray ionization imaging mass spectrometry of lipids in rat spinal cord , 2010, Journal of the American Society for Mass Spectrometry.
[2] E. Petricoin,et al. Clinical Proteomics: From Biomarker Discovery and Cell Signaling Profiles to Individualized Personal Therapy , 2005, Bioscience reports.
[3] Richard M Caprioli,et al. A Novel Histology-directed Strategy for MALDI-MS Tissue Profiling That Improves Throughput and Cellular Specificity in Human Breast Cancer* , 2006, Molecular & Cellular Proteomics.
[4] M. Setou,et al. Spatiotemporal alteration of phospholipids and prostaglandins in a rat model of spinal cord injury , 2012, Analytical and Bioanalytical Chemistry.
[5] A. Chiò. Risk factors in the early diagnosis of ALS: European epidemiological studies , 2000, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.
[6] R. Caprioli,et al. Identification of proteins directly from tissue: in situ tryptic digestions coupled with imaging mass spectrometry. , 2007, Journal of mass spectrometry : JMS.
[7] R. Tibshirani,et al. Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[8] N. Calcutt,et al. Considerations for quantification of lipids in nerve tissue using matrix-assisted laser desorption/ionization mass spectrometric imaging. , 2011, Rapid communications in mass spectrometry : RCM.
[9] K. Markides,et al. Cerebrospinal fluid protein patterns in neurodegenerative disease revealed by liquid chromatography‐Fourier transform ion cyclotron resonance mass spectrometry , 2004, Proteomics.
[10] L. Ungar,et al. Identification of potential CSF biomarkers in ALS , 2006, Neurology.
[11] L. Petrucelli,et al. Mechanism of neurodegenerative disease: role of the ubiquitin proteasome system , 2004, Annals of medicine.
[12] M. Karas,et al. Laser desorption ionization of proteins with molecular masses exceeding 10,000 daltons. , 1988, Analytical chemistry.
[13] F. Bertucci,et al. Protein Profiling of Human Breast Tumor Cells Identifies Novel Biomarkers Associated with Molecular Subtypes*S , 2008, Molecular & Cellular Proteomics.
[14] J. Haines,et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis , 1993, Nature.
[15] R. Caprioli,et al. MALDI Imaging Mass Spectrometry – Painting Molecular Pictures , 2010, Molecular oncology.
[16] M. Stoeckli,et al. Automated mass spectrometry imaging with a matrix-assisted laser desorption ionization time-of-flight instrument , 1999, Journal of the American Society for Mass Spectrometry.
[17] Richard M Caprioli,et al. Protein signatures for survival and recurrence in metastatic melanoma. , 2011, Journal of proteomics.
[18] H J Bennett,et al. How common is common? , 1991, Southern medical journal.
[19] Michelle L. Reyzer,et al. MALDI imaging mass spectrometry: molecular snapshots of biochemical systems , 2007, Nature Methods.
[20] Shyr Yu,et al. A novel comprehensive wave-form MS data processing method , 2009, Bioinform..
[21] J. Bergquist,et al. MALDI mass spectrometry based molecular phenotyping of CNS glial cells for prediction in mammalian brain tissue , 2011, Analytical and bioanalytical chemistry.
[22] Bart De Moor,et al. Prospective Exploration of Biochemical Tissue Composition via Imaging Mass Spectrometry Guided by Principal Component Analysis , 2006, Pacific Symposium on Biocomputing.
[23] Minh N. H. Nguyen,et al. Wild-Type Nonneuronal Cells Extend Survival of SOD1 Mutant Motor Neurons in ALS Mice , 2003, Science.
[24] Hanno Langen,et al. Biomarker Discovery by Imaging Mass Spectrometry , 2006, Molecular & Cellular Proteomics.
[25] Jonas Bergquist,et al. Imaging Mass Spectrometry Reveals Elevated Nigral Levels of Dynorphin Neuropeptides in L-DOPA-Induced Dyskinesia in Rat Model of Parkinson's Disease , 2011, PloS one.
[26] M. Mann,et al. Electrospray ionization for mass spectrometry of large biomolecules. , 1989, Science.
[27] J. Bergquist,et al. Focused proteomics in post-mortem human spinal cord. , 2006, Journal of proteome research.
[28] E. Melamed,et al. Spinal Cord mRNA Profile in Patients with ALS: Comparison with Transgenic Mice Expressing the Human SOD-1 Mutant , 2009, Journal of Molecular Neuroscience.
[29] Vanathi Gopalakrishnan,et al. Proteomic profiling of cerebrospinal fluid identifies biomarkers for amyotrophic lateral sclerosis , 2005, Journal of neurochemistry.
[30] A. Kalache,et al. Active ageing: a policy framework. , 2003, Advances in gerontology = Uspekhi gerontologii.
[31] Richard M Caprioli,et al. Molecular imaging of proteins in tissues by mass spectrometry , 2008, Proceedings of the National Academy of Sciences.
[32] R. Aebersold,et al. Mass Spectrometry and Protein Analysis , 2006, Science.
[33] Richard A Yost,et al. Imaging of lipids in spinal cord using intermediate pressure matrix-assisted laser desorption-linear ion trap/Orbitrap MS. , 2009, Analytical chemistry.
[34] J. Haines,et al. Mutations in UBQLN2 cause dominant X-linked juvenile and adult onset ALS and ALS/dementia , 2011, Nature.
[35] R. Aebersold,et al. Mass spectrometry-based proteomics , 2003, Nature.
[36] S. Rauser,et al. Normalization in MALDI-TOF imaging datasets of proteins: practical considerations , 2011, Analytical and bioanalytical chemistry.
[37] Richard M Caprioli,et al. Molecular analysis of tumor margins by MALDI mass spectrometry in renal carcinoma. , 2010, Journal of proteome research.
[38] Richard M Caprioli,et al. Molecular profiling of experimental Parkinson's disease: direct analysis of peptides and proteins on brain tissue sections by MALDI mass spectrometry. , 2004, Journal of proteome research.
[39] Richard M Caprioli,et al. Automated acoustic matrix deposition for MALDI sample preparation. , 2006, Analytical chemistry.
[40] D. Thurman,et al. How common are the “common” neurologic disorders? , 2007, Neurology.
[41] Y. Itoyama,et al. NEDL1, a Novel Ubiquitin-protein Isopeptide Ligase for Dishevelled-1, Targets Mutant Superoxide Dismutase-1* , 2004, Journal of Biological Chemistry.
[42] Yan Liu,et al. Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disorders. , 2006, Journal of Alzheimer's disease : JAD.
[43] Jacqueline Cristini,et al. misdiagnosis and missed diagnoses in patients with ALS , 2006, JAAPA : official journal of the American Academy of Physician Assistants.
[44] Richard M Caprioli,et al. Early Changes in Protein Expression Detected by Mass Spectrometry Predict Tumor Response to Molecular Therapeutics , 2004, Cancer Research.
[45] M. Stoeckli,et al. Imaging mass spectrometry: A new technology for the analysis of protein expression in mammalian tissues , 2001, Nature Medicine.
[46] Tyler A. Zimmerman,et al. The modified-bead stretched sample method: development and application to MALDI-MS imaging of protein localization in the spinal cord. , 2011, Chemical science.
[47] C. Ross,et al. Protein aggregation and neurodegenerative disease , 2004, Nature Medicine.
[48] T. Iwaki,et al. Involvement of cathepsin B in the motor neuron degeneration of amyotrophic lateral sclerosis , 2003, Acta Neuropathologica.
[49] R. Cooks,et al. Mapping lipid alterations in traumatically injured rat spinal cord by desorption electrospray ionization imaging mass spectrometry. , 2011, Analytical chemistry.
[50] Enikö Kövari,et al. Proteomics in human Parkinson's disease research. , 2009, Journal of proteomics.
[51] J. Sweedler,et al. SIMS and MALDI MS imaging of the spinal cord , 2008, Proteomics.
[52] R. Caprioli,et al. Molecular imaging of biological samples: localization of peptides and proteins using MALDI-TOF MS. , 1997, Analytical chemistry.